{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:08:17Z","timestamp":1782623297367,"version":"3.54.5"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN 2023KNIA-1058404"],"award-info":[{"award-number":["FRN 2023KNIA-1058404"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Assessing the quality of chronic kidney disease (CKD) management is crucial for optimal care and identifying care gaps. It is largely unknown which quality indicators have been widely used and the potential variations in the quality of CKD care. We sought to summarize process quality indicators for CKD and assess the quality of CKD care.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We searched databases including Medline (Ovid), PubMed, Cochrane Library, Web of Science, CINAHL, and Scopus from inception to June 20, 2024. Two reviewers screened the identified records, extracted relevant data, and classified categories and themes of quality indicators.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>We included 24 studies, extracted 30 quality indicators, and classified them into three categories with nine themes. The three categories included laboratory measures and monitoring of CKD progression and\/or complications (monitoring of kidney markers, CKD mineral and bone disorder, anemia and malnutrition, electrolytes, and volume), use of guideline-recommended therapeutic agents (use of medications), and attainment of therapeutic targets (blood pressure, glycemia, and lipids). Among the frequently reported quality indicators (in five or more studies), the following have a median proportion of study participants achieving that quality indicator exceeding 50%: monitoring of kidney markers (Scr\/eGFR), use of medications (ACEIs\/ARBs, avoiding non-steroidal anti-inflammatory drugs (NSAIDs)), management of blood pressure (with a target of \u2264140\/90, or without specific targets), and monitoring for glycated hemoglobin A1c (HbA1c)). The presence of diabetes, hypertension, cardiovascular disease, or proteinuria was associated with higher achievement in indicators of monitoring of kidney markers, use of recommended medications, and management of blood pressure and glycemia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The quality of CKD management varies with quality indicators. A more consistent and complete reporting of key quality indicators is needed for future studies assessing CKD care quality.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0309973","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:27:31Z","timestamp":1733855251000},"page":"e0309973","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the quality of CKD care using process quality indicators: A scoping review"],"prefix":"10.1371","volume":"19","author":[{"given":"Na","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminu K.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2238-7528","authenticated-orcid":true,"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"issue":"10225","key":"pone.0309973.ref001","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"1","key":"pone.0309973.ref002","first-page":"5","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group","year":"2013","journal-title":"Kidney Int"},{"issue":"1","key":"pone.0309973.ref003","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nefroe.2021.09.005","article-title":"CKD: The burden of disease invisible to research funders","volume":"42","author":"AIRG-E E","year":"2022","journal-title":"Nefrologia (Engl Ed)"},{"issue":"11","key":"pone.0309973.ref004","doi-asserted-by":"crossref","first-page":"e3013","DOI":"10.1097\/MD.0000000000003013","article-title":"Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis","volume":"95","author":"WC Tsai","year":"2016","journal-title":"Medicine"},{"issue":"3","key":"pone.0309973.ref005","first-page":"305","article-title":"Risk and lifestyle factors associated to chronic kidney disease","volume":"58","author":"SM L\u00f3pez-Heydeck","year":"2020","journal-title":"Revista medica del Instituto Mexicano del Seguro Social"},{"issue":"1","key":"pone.0309973.ref006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11606-015-3452-x","article-title":"Influence of Nephrologist Care on Management and Outcomes in Adults with Chronic Kidney Disease","volume":"31","author":"AC Ricardo","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"2","key":"pone.0309973.ref007","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.amjmed.2015.08.025","article-title":"Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician","volume":"129","author":"JA Vassalotti","year":"2016","journal-title":"The American journal of medicine"},{"issue":"4","key":"pone.0309973.ref008","doi-asserted-by":"crossref","first-page":"e008480","DOI":"10.1136\/bmjopen-2015-008480","article-title":"What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial","volume":"6","author":"A Nihat","year":"2016","journal-title":"BMJ open"},{"issue":"10","key":"pone.0309973.ref009","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/ijcp.12878","article-title":"Process quality indicators for chronic kidney disease risk management: a systematic literature review","volume":"70","author":"KP Smits","year":"2016","journal-title":"Int J Clin Pract"},{"issue":"14","key":"pone.0309973.ref010","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/jama.2017.1964","article-title":"Vital Directions for Health and Health Care: Priorities From a National Academy of Medicine Initiative","volume":"317","author":"VJ Dzau","year":"2017","journal-title":"Jama"},{"issue":"1","key":"pone.0309973.ref011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12882-020-01788-8","article-title":"Developing quality indicators for Chronic Kidney Disease in primary care, extractable from the Electronic Medical Record. A Rand-modified Delphi method","volume":"21","author":"SA Van den Bulck","year":"2020","journal-title":"BMC Nephrol"},{"issue":"1","key":"pone.0309973.ref012","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12882-018-1048-5","article-title":"Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines","volume":"19","author":"GFC Weckmann","year":"2018","journal-title":"BMC Nephrol"},{"issue":"9","key":"pone.0309973.ref013","doi-asserted-by":"crossref","first-page":"e1910704","DOI":"10.1001\/jamanetworkopen.2019.10704","article-title":"Quality of Chronic Kidney Disease Management in Canadian Primary Care","volume":"2","author":"AK Bello","year":"2019","journal-title":"JAMA network open"},{"issue":"1","key":"pone.0309973.ref014","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/02813432.2015.1132885","article-title":"Quality of chronic kidney disease management in primary care: a retrospective study","volume":"34","author":"VA Van Gelder","year":"2016","journal-title":"Scand J Prim Health Care"},{"issue":"5","key":"pone.0309973.ref015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.08720816","article-title":"A Population-Based Analysis of Quality Indicators in CKD","volume":"12","author":"L Manns","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"pone.0309973.ref016","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"AC Tricco","year":"2018","journal-title":"Annals of internal medicine"},{"issue":"1","key":"pone.0309973.ref017","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Z Munn","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"pone.0309973.ref018","unstructured":"Chronic kidney disease: assessment and management. London: National Institute for Health and Care Excellence (NICE). 2021."},{"key":"pone.0309973.ref019","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"pone.0309973.ref020","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1503\/cmaj.080351","article-title":"Guidelines for the management of chronic kidney disease","volume":"179","author":"A Levin","year":"2008","journal-title":"CMAJ: Canadian Medical Association journal = journal de l\u2019Association medicale canadienne"},{"issue":"05","key":"pone.0309973.ref021","first-page":"735","article-title":"Guidelines for early screening, diagnosis, prevention and treatment of chronic kidney disease (2022 Edition)","volume":"38","author":"Expert Group on Kidney Clinical Quality Control Center in Shanghai","year":"2022","journal-title":"Chin J Nephrol"},{"key":"pone.0309973.ref022","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2369-15-70","article-title":"Electronic problem list documentation of chronic kidney disease and quality of care","volume":"15","author":"L Samal","year":"2014","journal-title":"BMC Nephrol"},{"issue":"8","key":"pone.0309973.ref023","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1742-1241.2006.01028.x","article-title":"Management of advanced chronic kidney disease in primary care\u2014current data from Germany","volume":"60","author":"S Herget-Rosenthal","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"1","key":"pone.0309973.ref024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1470320314550018","article-title":"Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study","volume":"16","author":"L Tylicki","year":"2015","journal-title":"Journal of the renin-angiotensin-aldosterone system: JRAAS"},{"issue":"4","key":"pone.0309973.ref025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11606-010-1523-6","article-title":"Primary care management of chronic kidney disease","volume":"26","author":"AS Allen","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"8","key":"pone.0309973.ref026","doi-asserted-by":"crossref","first-page":"e0272662","DOI":"10.1371\/journal.pone.0272662","article-title":"Quality and variation of care for chronic kidney disease in Swiss general practice: A retrospective database study","volume":"17","author":"L J\u00e4ger","year":"2022","journal-title":"PLoS One"},{"key":"pone.0309973.ref027","doi-asserted-by":"crossref","first-page":"2054358117703059","DOI":"10.1177\/2054358117703059","article-title":"Quality of Care for Patients With Chronic Kidney Disease in the Primary Care Setting: A Retrospective Cohort Study From Ontario, Canada","volume":"4","author":"DM Nash","year":"2017","journal-title":"Can J Kidney Health Dis"},{"issue":"7","key":"pone.0309973.ref028","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/MLR.0000000000001301","article-title":"Quality of Care in Chronic Kidney Disease and Incidence of End-stage Renal Disease in Older Patients: A Cohort Study","volume":"58","author":"S Fukuma","year":"2020","journal-title":"Medical care"},{"issue":"12","key":"pone.0309973.ref029","doi-asserted-by":"crossref","first-page":"632","DOI":"10.47102\/annals-acadmedsg.V42N12p632","article-title":"Quality of care of patients with chronic kidney disease in national healthcare group polyclinics from 2007 to 2011","volume":"42","author":"GY Ang","year":"2013","journal-title":"Annals of the Academy of Medicine, Singapore"},{"issue":"3","key":"pone.0309973.ref030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.51866\/oa1171","article-title":"A clinical audit of the diagnosis and management of chronic kidney disease in a primary care clinic","volume":"16","author":"J Jamaluddin","year":"2021","journal-title":"Malaysian family physician: the official journal of the Academy of Family Physicians of Malaysia"},{"issue":"4","key":"pone.0309973.ref031","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/fampra\/cmx002","article-title":"Adherence to chronic kidney disease guidelines in primary care patients is associated with comorbidity","volume":"34","author":"C van Dipten","year":"2017","journal-title":"Fam Pract"},{"issue":"3","key":"pone.0309973.ref032","doi-asserted-by":"crossref","first-page":"132","DOI":"10.31128\/AJGP-07-18-4630","article-title":"Chronic kidney disease monitoring in Australian general practice","volume":"48","author":"MA Khanam","year":"2019","journal-title":"Australian journal of general practice"},{"issue":"9","key":"pone.0309973.ref033","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/dme.13014","article-title":"Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry","volume":"33","author":"AO Luk","year":"2016","journal-title":"Diabet Med"},{"issue":"7","key":"pone.0309973.ref034","doi-asserted-by":"crossref","first-page":"e025784","DOI":"10.1136\/bmjopen-2018-025784","article-title":"Prescribing quality in secondary care patients with different stages of chronic kidney disease: a retrospective study in the Netherlands","volume":"9","author":"KP Smits","year":"2019","journal-title":"BMJ open"},{"issue":"2","key":"pone.0309973.ref035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ki.2010.376","article-title":"Quality of care and mortality are worse in chronic kidney disease patients living in remote areas","volume":"79","author":"D Rucker","year":"2011","journal-title":"Kidney Int"},{"issue":"2","key":"pone.0309973.ref036","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.ajkd.2022.07.009","article-title":"Risk of CKD Progression and Quality-of-Care Indicators in the Primary Care Setting","volume":"81","author":"J Yuen","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"pone.0309973.ref037","doi-asserted-by":"crossref","first-page":"904","DOI":"10.34067\/KID.0000532020","article-title":"Screening and Recognition of Chronic Kidney Disease in VA Health Care System Primary Care Clinics","volume":"1","author":"S Bansal","year":"2020","journal-title":"Kidney360"},{"issue":"10","key":"pone.0309973.ref038","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1681\/ASN.2022030373","article-title":"Sex Differences in the Recognition, Monitoring, and Management of CKD in Health Care: An Observational Cohort Study","volume":"33","author":"O Swartling","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"pone.0309973.ref039","doi-asserted-by":"crossref","first-page":"E74","DOI":"10.9778\/cmajo.20160113","article-title":"Quality indicators for the detection and management of chronic kidney disease in primary care in Canada derived from a modified Delphi panel approach","volume":"5","author":"K Tu","year":"2017","journal-title":"CMAJ Open"},{"issue":"3","key":"pone.0309973.ref040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/jcm9030783","article-title":"Medication Prescribing Quality in Australian Primary Care Patients with Chronic Kidney Disease","volume":"9","author":"WM Bezabhe","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"pone.0309973.ref041","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12882-019-1260-y","article-title":"Development of an electronic health record-based chronic kidney disease registry to promote population health management","volume":"20","author":"ML Mendu","year":"2019","journal-title":"BMC Nephrol"},{"key":"pone.0309973.ref042","author":"BA-O Agvall","year":"2023","journal-title":"Characteristics, management and outcomes in patients with CKD in a healthcare region in Sweden: a population-based, observational study"},{"issue":"1","key":"pone.0309973.ref043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"7","author":"Kidney Disease: Improving Global Outcomes Work Group","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"key":"pone.0309973.ref044","first-page":"279","article-title":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease","volume":"2","author":"Kidney Disease: Improving Global Outcomes Work Group","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"3s","key":"pone.0309973.ref045","first-page":"S1","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2021","journal-title":"Kidney Int"},{"issue":"9","key":"pone.0309973.ref046","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.01660214","article-title":"Implementation of a CKD checklist for primary care providers","volume":"9","author":"ML Mendu","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5S","key":"pone.0309973.ref047","first-page":"S1","article-title":"KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"102","author":"Kidney Disease: Improving Global Outcomes Diabetes Work Group","year":"2022","journal-title":"Kidney Int"},{"key":"pone.0309973.ref048","first-page":"259","article-title":"KDIGO clinical practice guideline for lipid managment in chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"4S","key":"pone.0309973.ref049","first-page":"S1","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group","year":"2021","journal-title":"Kidney Int"},{"issue":"13","key":"pone.0309973.ref050","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic Kidney Disease Diagnosis and Management: A Review","volume":"322","author":"TK Chen","year":"2019","journal-title":"Jama"},{"issue":"5","key":"pone.0309973.ref051","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MNH.0000000000000907","article-title":"Medication safety in chronic kidney disease","volume":"32","author":"S. Singh","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"pone.0309973.ref052","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s40620-020-00895-x","article-title":"Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change wheel","volume":"34","author":"WH Tesfaye","year":"2021","journal-title":"Journal of nephrology"},{"issue":"1","key":"pone.0309973.ref053","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12882-020-01731-x","article-title":"Barriers and enablers to detection and management of chronic kidney disease in primary healthcare: a systematic review","volume":"21","author":"EP Neale","year":"2020","journal-title":"BMC Nephrol"},{"issue":"8","key":"pone.0309973.ref054","doi-asserted-by":"crossref","first-page":"e0221325","DOI":"10.1371\/journal.pone.0221325","article-title":"Primary care physicians\u2019 perceptions of barriers and facilitators to management of chronic kidney disease: A mixed methods study","volume":"14","author":"CJ Sperati","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"pone.0309973.ref055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2010.39","article-title":"Relation between kidney function, proteinuria, and adverse outcomes","volume":"303","author":"BR Hemmelgarn","year":"2010","journal-title":"Jama"},{"issue":"8","key":"pone.0309973.ref056","doi-asserted-by":"crossref","first-page":"e2225821","DOI":"10.1001\/jamanetworkopen.2022.25821","article-title":"Association of Albuminuria and Regression of Chronic Kidney Disease in Adults With Newly Diagnosed Moderate to Severe Chronic Kidney Disease","volume":"5","author":"M Pasternak","year":"2022","journal-title":"JAMA network open"},{"issue":"10","key":"pone.0309973.ref057","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamainternmed.2021.4813","article-title":"Accounting for Age in the Definition of Chronic Kidney Disease","volume":"181","author":"P Liu","year":"2021","journal-title":"JAMA internal medicine"},{"key":"pone.0309973.ref058","unstructured":"Eckardt KU, Delgado C, Heerspink HJL, Pecoits-Filho R, Ricardo AC, Stengel B, et al. Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (1523\u20131755 (Electronic))."},{"key":"pone.0309973.ref059","doi-asserted-by":"crossref","first-page":"869899","DOI":"10.3389\/fendo.2022.869899","article-title":"Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease","volume":"13","author":"J Ling","year":"2022","journal-title":"Frontiers in endocrinology"},{"issue":"4","key":"pone.0309973.ref060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40265-019-1064-1","article-title":"Management of Hypertension in Chronic Kidney Disease","volume":"79","author":"D Pugh","year":"2019","journal-title":"Drugs"},{"key":"pone.0309973.ref061","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","article-title":"Diabetic kidney disease","volume":"1","author":"MC Thomas","year":"2015","journal-title":"Nature reviews Disease primers"},{"issue":"1","key":"pone.0309973.ref062","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12325-021-01994-2","article-title":"Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape","volume":"39","author":"CW Mende","year":"2022","journal-title":"Adv Ther"},{"issue":"1","key":"pone.0309973.ref063","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/ckj\/sfac189","article-title":"SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence","volume":"16","author":"Z Kalay","year":"2023","journal-title":"Clin Kidney J"},{"issue":"4S","key":"pone.0309973.ref064","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0309973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:28:00Z","timestamp":1733855280000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0309973"}},"subtitle":[],"editor":[{"given":"Ankur","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0309973","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]}}}